Leukemia & Lymphoma, Volume 60, Issue 1 (2019)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Leukemia & Lymphoma, Volume 60, Issue 1 (2019)

See all volumes and issues
Vol 65, 2024 Vol 64, 2023 Vol 63, 2022 Vol 62, 2021 Vol 61, 2020 Volume 60, 2019 Vol 59, 2018 Vol 58, 2017 Vol 57, 2016 Vol 56, 2015 Vol 55, 2014 Vol 54, 2013 Vol 53, 2012 Vol 52, 2011 Vol 51, 2010 Vol 50, 2009 Vol 49, 2008 Vol 48, 2007 Vol 47, 2006 Vol 46, 2005 Vol 45, 2004 Vol 44, 2003 Vol 43, 2002 Vol 42, 2001 Vol 41, 2001 Vol 40, 2000-2001 Vol 39, 2000 Vol 38, 2000 Vol 37, 2000 Vol 36, 1999-2000 Vol 35, 1999 Vol 34, 1999 Vol 33, 1999 Vol 32, 1998-1999 Vol 31, 1998 Vol 30, 1998 Vol 29, 1998 Vol 28, 1997-1998 Vol 27, 1997 Vol 26, 1997 Vol 25, 1997 Vol 24, 1996-1997 Vol 23, 1996 Vol 22, 1996 Vol 21, 1996 Vol 20, 1995-1996 Vol 19, 1995 Vol 18, 1995 Vol 17, 1995 Vol 16, 1995 Vol 15, 1995 Vol 16, 1995 Vol 15, 1995 Vol 14, 1994 Vol 13, 1994 Vol 12, 1993-1994 Vol 11, 1993 Vol 10, 1993 Vol 9, 1993 Vol 8, 1992 Vol 7, 1992 Vol 6, 1991-1992 Vol 5, 1991 Vol 4, 1991 Vol 3, 1990-1991 Vol 2, 1990 Vol 1, 1989-1990
Download citations Download PDFs

Commentary

LeukeMYC prognostication
Katherine L. B. Knorr & Martin S. Tallman
Pages: 1-2
Published online: 06 Jul 2018
CitationforLeukeMYC prognostication | Full Text | References | PDF (237.7 KB) | EPUB
  • 141 Views
  • 2 CrossRef citations
  • 0Altmetric
A renaissance for autologous transplantation in follicular lymphoma?
Ok-Kyong Chaekal & Koen van Besien
Pages: 3-5
Published online: 03 Jul 2018
First Page PreviewforA renaissance for autologous transplantation in follicular lymphoma? | Full Text | References | PDF (298.7 KB) | EPUB | Supplemental
  • 240 Views
  • 0 CrossRef citations
  • 0Altmetric

Review

Treatment of newly diagnosed primary central nervous system lymphoma: current and emerging therapies
Tarsheen K. Sethi & Nishitha M. Reddy
Pages: 6-18
Published online: 09 May 2018
AbstractforTreatment of newly diagnosed primary central nervous system lymphoma: current and emerging therapies | Full Text | References | PDF (1.3 MB) | EPUB | Supplemental
  • 508 Views
  • 4 CrossRef citations
  • 0Altmetric
Hemophagocytic lymphohistiocytosis in adults
Neel S. Bhatt, Benjamin Oshrine & Julie An Talano
Pages: 19-28
Published online: 03 Jul 2018
AbstractforHemophagocytic lymphohistiocytosis in adults | Full Text | References | PDF (769.8 KB) | EPUB | Supplemental
  • 2147 Views
  • 24 CrossRef citations
  • 0Altmetric
Extracellular vesicles in hematological malignancies
Zofia Litwińska, Karolina Łuczkowska & Bogusław Machaliński
Pages: 29-36
Published online: 10 May 2018
AbstractforExtracellular vesicles in hematological malignancies | Full Text | References | PDF (635.2 KB) | EPUB | Supplemental
  • 565 Views
  • 18 CrossRef citations
  • 0Altmetric

Original Article: Research

MYC protein expression is an important prognostic factor in acute myeloid leukemia
Maro Ohanian, Uri Rozovski, Rashmi Kanagal-Shamanna, Lynne V. Abruzzo, Sanam Loghavi, Tapan Kadia, Andrew Futreal, Kapil Bhalla, Zhuang Zuo, Yang O. Huh, Sean M. Post, Peter Ruvolo, Guillermo Garcia-Manero, Michael Andreeff, Steven Kornblau, Gautam Borthakur, Peter Hu, L. Jeffrey Medeiros, Koichi Takahashi, Marisa J. Hornbaker, Jianhua Zhang, Graciela M. Nogueras-González, Xuelin Huang, Srdan Verstovsek, Zeev Estrov, Sherry Pierce, Farhad Ravandi, Hagop M. Kantarjian, Carlos E. Bueso-Ramos & Jorge E. Cortes
Pages: 37-48
Published online: 09 May 2018
AbstractforMYC protein expression is an important prognostic factor in acute myeloid leukemia | Full Text | References | PDF (2.2 MB) | EPUB | Supplemental
  • 884 Views
  • 46 CrossRef citations
  • 0Altmetric

Original Article: Clinical

Transfusion-free interval is associated with improved survival in patients with higher-risk myelodysplastic syndromes engaged in routine care
Jill A. Bell, Aaron Galaznik, Marlo Blazer, Eileen Farrelly, Augustina Ogbonnaya, Aditya Raju, Michael Eaddy, Robert J. Fram & Douglas V. Faller
Pages: 49-59
Published online: 22 Jun 2018
AbstractforTransfusion-free interval is associated with improved survival in patients with higher-risk myelodysplastic syndromes engaged in routine care | Full Text | References | PDF (1.6 MB) | EPUB | Supplemental
  • 2253 Views
  • 7 CrossRef citations
  • 0Altmetric
Open Access
Daunorubicin during delayed intensification decreases the incidence of infectious complications – a randomized comparison in trial CoALL 08-09
Franziska Schramm, Martin Zimmermann, Norbert Jorch, Arnulf Pekrun, Arndt Borkhardt, Thomas Imschweiler, Holger Christiansen, Jörg Faber, Tobias Feuchtinger, Irene Schmid, Gerhard Beron, Martin A. Horstmann & Gabriele Escherich
Pages: 60-68
Published online: 03 Jul 2018
AbstractforDaunorubicin during delayed intensification decreases the incidence of infectious complications – a randomized comparison in trial CoALL 08-09 | Full Text | References | PDF (1.1 MB) | EPUB | Supplemental
  • 272 Views
  • 6 CrossRef citations
  • 0Altmetric
AML: high serum ferritin at initial diagnosis has a negative impact on long-term survival
Jana Ihlow, Sophia Gross, Annabel Sick, Tanja Schneider, Anne Flörcken, Thomas Burmeister, Seval Türkmen, Renate Arnold, Bernd Dörken & Jörg Westermann
Pages: 69-77
Published online: 30 May 2018
AbstractforAML: high serum ferritin at initial diagnosis has a negative impact on long-term survival | Full Text | References | PDF (1 MB) | EPUB | Supplemental
  • 325 Views
  • 13 CrossRef citations
  • 0Altmetric
Osteonecrosis in children with acute lymphoblastic leukemia at initial diagnosis and prior to any chemotherapy
Kathinka Krull, Marina Kunstreich, Annika Bronsema, Kirsten Bleckmann, Carl-Friedrich Classen, Bernhard Erdlenbruch, Norbert Jorch, Reinhard Kolb, Alfred Leipold, Olga Moser, Aram Prokop, Wolfram Scheurlen, Daniel Steinbach, Janina Klasen-Sansone, Dirk Klee, Gabriele Escherich, Anja Moericke, Martin Schrappe, Arndt Borkhardt & Michaela Kuhlen
Pages: 78-84
Published online: 02 May 2018
AbstractforOsteonecrosis in children with acute lymphoblastic leukemia at initial diagnosis and prior to any chemotherapy | Full Text | References | PDF (1,023.5 KB) | EPUB | Supplemental
  • 421 Views
  • 9 CrossRef citations
  • 0Altmetric
Clinical characteristics and treatment outcomes among respiratory syncytial virus (RSV)-infected hematologic malignancy and hematopoietic stem cell transplant recipients receiving palivizumab
Nitipong Permpalung, Monica V. Mahoney, Christopher McCoy, Amporn Atsawarungruangkit, Howard S. Gold, James D. Levine, Michael T. Wong, Mary T. LaSalvia & Carolyn D. Alonso
Pages: 85-91
Published online: 27 Jun 2018
AbstractforClinical characteristics and treatment outcomes among respiratory syncytial virus (RSV)-infected hematologic malignancy and hematopoietic stem cell transplant recipients receiving palivizumab | Full Text | References | PDF (600.1 KB) | EPUB | Supplemental
  • 539 Views
  • 8 CrossRef citations
  • 0Altmetric
A phase 2 study of ofatumumab (Arzerra®) in combination with a pan-AKT inhibitor (afuresertib) in previously treated patients with chronic lymphocytic leukemia (CLL)*
Christine I. Chen, Harminder Paul, Lisa W. Le, Ellen N. Wei, Susi Snitzler, Trina Wang, Olga Levina, Sumeet Kakar, Anthea Lau, Michelle Queau, James B. Johnston, Deborah A. Smith & Suzanne Trudel
Pages: 92-100
Published online: 19 Jun 2018
AbstractforA phase 2 study of ofatumumab (Arzerra®) in combination with a pan-AKT inhibitor (afuresertib) in previously treated patients with chronic lymphocytic leukemia (CLL)* | Full Text | References | PDF (918.6 KB) | EPUB | Supplemental
  • 248 Views
  • 4 CrossRef citations
  • 0Altmetric
Allogeneic transplantation for relapsed and refractory Hodgkin lymphoma: long-term outcomes and graft-versus-host disease-free/relapse-free survival
Francesco Spina, Tommaso Radice, Chiara De Philippis, Martina Soldarini, Maria Chiara Di Chio, Anna Dodero, Anna Guidetti, Simonetta Viviani & Paolo Corradini
Pages: 101-109
Published online: 01 May 2018
AbstractforAllogeneic transplantation for relapsed and refractory Hodgkin lymphoma: long-term outcomes and graft-versus-host disease-free/relapse-free survival | Full Text | References | PDF (864.3 KB) | EPUB | Supplemental
  • 528 Views
  • 7 CrossRef citations
  • 0Altmetric
Single dose versus multiple doses of rituximab for preemptive therapy of Epstein–Barr virus reactivation after hematopoietic cell transplantation
Tania Jain, Heidi E. Kosiorek, Thomas E. Grys, Shu Ting Kung, Vishal S. Shah, Jeffrey A. Betcher, James L. Slack, Jose F. Leis, Nandita Khera, Pierre Noel, Jeanne M. Palmer & Lisa Z. Sproat
Pages: 110-117
Published online: 06 Jul 2018
AbstractforSingle dose versus multiple doses of rituximab for preemptive therapy of Epstein–Barr virus reactivation after hematopoietic cell transplantation | Full Text | References | PDF (678.2 KB) | EPUB | Supplemental
  • 517 Views
  • 9 CrossRef citations
  • 0Altmetric
Secondary plasma cell leukemia: a multicenter retrospective study of 101 patients
Artur Jurczyszyn, Jorge J. Castillo, Irit Avivi, Jacek Czepiel, Julio Davila, Ravi Vij, Mark A. Fiala, Alessandro Gozzetti, Norbert Grząśko, Vibor Milunovic, Iwona Hus, Krzysztof Mądry, Anna Waszczuk-Gajda, Lidia Usnarska-Zubkiewicz, Jakub Dębski, Erden Atilla, Meral Beksac, Giuseppe Mele, Waldemar Sawicki, David Jayabalan, Grzegorz Charliński, Agoston Gyula Szabo, Roman Hajek, Michel Delforge, Agnieszka Kopacz, Dorotea Fantl, Anders Waage, Edvan Crusoe, Vania Hungria, Paul Richardson, Jacob Laubach, Thomas Guerrero-Garcia, Jieqi Liu & David H. Vesole
Pages: 118-123
Published online: 02 Jul 2018
AbstractforSecondary plasma cell leukemia: a multicenter retrospective study of 101 patients | Full Text | References | PDF (835.4 KB) | EPUB | Supplemental
  • 782 Views
  • 17 CrossRef citations
  • 0Altmetric
Article
Infectious complications in children treated for hodgkin and non-hodgkin lymphomas in polish pediatric leukemia/lymphoma study group: incidence, epidemiology and etiology
Olga Zajac-Spychala, Jacek Wachowiak, Anna Szmydki-Baran, Lukasz Hutnik, Malgorzata Salamonowicz, Michal Matysiak, Krzysztof Czyzewski, Mariusz Wysocki, Patrycja Zalas-Wiecek, Zofia Malas, Wanda Badowska, Olga Gryniewicz-Kwiatkowska, Aneta Czajnska-Deptuła, Elwira Kulicka, Bozenna Dembowska-Baginska, Danuta Perek, Katarzyna Semczuk, Katarzyna Dzierzanowska-Fangrat, Tomasz Ociepa, Magdalena Bartnik, Liliana Chelmecka-Wiktorczyk, Walentyna Balwierz, Joanna Klepacka, Nina Irga-Jaworska, Ewa Bien, Elzbieta Adamkiewicz-Drozynska, Agnieszka Urbanek-Dadela, Grazyna Karolczyk, Filip Pierlejewski, Wojciech Mlynarski, Marcin Plonowski, Maryna Krawczuk-Rybak, Weronika Stolpa, Grazyna Sobol, Renata Tomaszewska, Tomasz Szczepanski, Zuzanna Gamrot, Mariola Woszczyk, Maria Wieczorek, Jerzy Kowalczyk & Jan Styczynski
Pages: 124-132
Published online: 05 Nov 2018
AbstractforInfectious complications in children treated for hodgkin and non-hodgkin lymphomas in polish pediatric leukemia/lymphoma study group: incidence, epidemiology and etiology | Full Text | References | PDF (750.6 KB) | EPUB | Supplemental
  • 371 Views
  • 5 CrossRef citations
  • 0Altmetric
Autologous transplantation improves survival rates for follicular lymphoma patients who relapse within two years of chemoimmunotherapy: a multi-center retrospective analysis of consecutively treated patients in the real world
Mita Manna, Richard Lee-Ying, Gwynivere Davies, Colin Stewart, Danielle H. Oh, Anthea Peters & Douglas A. Stewart
Pages: 133-141
Published online: 03 Jul 2018
AbstractforAutologous transplantation improves survival rates for follicular lymphoma patients who relapse within two years of chemoimmunotherapy: a multi-center retrospective analysis of consecutively treated patients in the real world | Full Text | References | PDF (1.6 MB) | EPUB | Supplemental
  • 499 Views
  • 13 CrossRef citations
  • 0Altmetric
Post-transplant lymphoproliferative disorders after solid organ and hematopoietic stem cell transplantation
Samuel Romero, Juan Montoro, Marta Guinot, Luis Almenar, Rafael Andreu, Aitana Balaguer, Isabel Beneyto, Jordi Espí, José Gómez-Codina, Gloria Iacoboni, Isidro Jarque, Rafael López-Andújar, Empar Mayordomo-Aranda, Joaquín Montalar, Amparo Pastor, Miguel Pastor, José L. Piñana, Nohelia Rojas-Ferrer, Ignacio Sánchez-Lázaro, Jesús Sandoval, Guillermo Sanz, Miguel Á. Sanz, Amparo Solé & Jaime Sanz
Pages: 142-150
Published online: 03 Jul 2018
AbstractforPost-transplant lymphoproliferative disorders after solid organ and hematopoietic stem cell transplantation | Full Text | References | PDF (764.9 KB) | EPUB | Supplemental
  • 1152 Views
  • 30 CrossRef citations
  • 0Altmetric
A comparison of the efficacy of immunomodulatory-free regimens in relapsed or refractory multiple myeloma: a network meta-analysis
Katja Weisel, Pieter Sonneveld, Andrew Spencer, Meral Beksac, Maria Rizzo, Yingxin Xu, Kyle Fahrbach, Maren Gaudig, Mary Slavcev, Lindsay Dearden & Annette Lam
Pages: 151-162
Published online: 08 Nov 2018
AbstractforA comparison of the efficacy of immunomodulatory-free regimens in relapsed or refractory multiple myeloma: a network meta-analysis | Full Text | References | PDF (1.2 MB) | EPUB | Supplemental
  • 3334 Views
  • 6 CrossRef citations
  • 0Altmetric
Open Access

Original Article: Research

Propensity score matching analysis to evaluate the comparative effectiveness of daratumumab versus real-world standard of care therapies for patients with heavily pretreated and refractory multiple myeloma
Shaji Kumar, Brian Durie, Hareth Nahi, Ravi Vij, Meletios A. Dimopoulos, Efstathios Kastritis, Evangelos Terpos, Xavier Leleu, Meral Beksac, Hartmut Goldschmidt, Jens Hillengass, Zhuo Su, Brian Hutton, Chris Cameron, Imran Khan & Annette Lam
Pages: 163-171
Published online: 09 May 2018
AbstractforPropensity score matching analysis to evaluate the comparative effectiveness of daratumumab versus real-world standard of care therapies for patients with heavily pretreated and refractory multiple myeloma | Full Text | References | PDF (1.2 MB) | EPUB | Supplemental
  • 1088 Views
  • 9 CrossRef citations
  • 0Altmetric

Original Article: Clinical

Association between bortezomib dose intensity and overall survival in mantle cell lymphoma patients on frontline VR-CAP in the phase 3 LYM-3002 study
Tadeusz Robak, Huiqiang Huang, Jie Jin, Jun Zhu, Ting Liu, Olga Samoilova, Halyna Pylypenko, Gregor Verhoef, Noppadol Siritanaratkul, Evgenii Osmanov, Juliana Pereira, Jiri Mayer, Xiaonan Hong, Rumiko Okamoto, Lixia Pei, Brendan Rooney, Helgi van de Velde & Franco Cavalli
Pages: 172-179
Published online: 05 Jun 2017
AbstractforAssociation between bortezomib dose intensity and overall survival in mantle cell lymphoma patients on frontline VR-CAP in the phase 3 LYM-3002 study | Full Text | References | PDF (953.6 KB) | EPUB | Supplemental
  • 2607 Views
  • 10 CrossRef citations
  • 0Altmetric
Open Access

Original Article: Research

Expression of CRBN, IKZF1, and IKZF3 does not predict lenalidomide sensitivity and mutations in the cereblon pathway are infrequent in multiple myeloma
Konstantinos Dimopoulos, Helga Fibiger Munch-Petersen, Christian Winther Eskelund, Lene Dissing Sjö, Elisabeth Ralfkiaer, Peter Gimsing & Kirsten Grønbaek
Pages: 180-188
Published online: 02 May 2018
AbstractforExpression of CRBN, IKZF1, and IKZF3 does not predict lenalidomide sensitivity and mutations in the cereblon pathway are infrequent in multiple myeloma | Full Text | References | PDF (1.8 MB) | EPUB | Supplemental
  • 1021 Views
  • 21 CrossRef citations
  • 0Altmetric
Bosutinib, dasatinib, imatinib, nilotinib, and ponatinib differentially affect the vascular molecular pathways and functionality of human endothelial cells
Ayala Gover-Proaktor, Galit Granot, Metsada Pasmanik-Chor, Oren Pasvolsky, Saar Shapira, Oshrat Raz, Pia Raanani & Avi Leader
Pages: 189-199
Published online: 09 May 2018
AbstractforBosutinib, dasatinib, imatinib, nilotinib, and ponatinib differentially affect the vascular molecular pathways and functionality of human endothelial cells | Full Text | References | PDF (2.5 MB) | EPUB | Supplemental
  • 1428 Views
  • 37 CrossRef citations
  • 0Altmetric
Deep sequencing of BCR-ABL1 kinase domain mutations in chronic myeloid leukemia patients with resistance to tyrosine kinase inhibitors
Yucel Erbilgin, Ahmet Emre Eskazan, Ozden Hatirnaz Ng, Ayse Salihoglu, Tugrul Elverdi, Sinem Firtina, Orcun Tasar, Sevcan Mercan, Sinem Sisko, Khusan Khodzhaev, Seniz Ongoren, Muhlis Cem Ar, Zafer Baslar, Teoman Soysal, Muge Sayitoglu & Ugur Ozbek
Pages: 200-207
Published online: 02 Jul 2018
AbstractforDeep sequencing of BCR-ABL1 kinase domain mutations in chronic myeloid leukemia patients with resistance to tyrosine kinase inhibitors | Full Text | References | PDF (1.5 MB) | EPUB | Supplemental
  • 580 Views
  • 10 CrossRef citations
  • 0Altmetric
Clinical significance of HLA-E genotype and surface/soluble expression levels between healthy individuals and patients with acute leukemia
Yun-Ping Xu, Lotte Wieten, Song-Xing Wang, Yun Cai, Timo Olieslagers, Li Zhang, Liu-Mei He, Marce G. J. Tilanus & Wen-Xu Hong
Pages: 208-215
Published online: 03 Jul 2018
AbstractforClinical significance of HLA-E genotype and surface/soluble expression levels between healthy individuals and patients with acute leukemia | Full Text | References | PDF (1.1 MB) | EPUB | Supplemental
  • 301 Views
  • 11 CrossRef citations
  • 0Altmetric
Inter-individual variation in imatinib disposition: any role for prevalent variants of CYP1A2, CYP2C8, CYP2C9, and CYP3A5 in Nigerian CML patients?
Ayorinde Adehin, Babatunde A. Adeagbo, Martin A. Kennedy, Oluseye O. Bolaji, Tiwalade A. Olugbade, Rahman A. Bolarinwa & Muheez A. Durosinmi
Pages: 216-221
Published online: 09 May 2018
AbstractforInter-individual variation in imatinib disposition: any role for prevalent variants of CYP1A2, CYP2C8, CYP2C9, and CYP3A5 in Nigerian CML patients? | Full Text | References | PDF (890.3 KB) | EPUB | Supplemental
  • 225 Views
  • 6 CrossRef citations
  • 0Altmetric

Letter to the Editor

Added prognostic value of FDG-PET/CT in relapsing multiple myeloma patients
Bastien Jamet, Clément Bailly, Thomas Carlier, Lucie Planche, Cyrille Touzeau, Françoise Kraeber-Bodéré, Philippe Moreau & Caroline Bodet-Milin
Pages: 222-225
Published online: 02 May 2018
First Page PreviewforAdded prognostic value of FDG-PET/CT in relapsing multiple myeloma patients | Full Text | References | PDF (781.1 KB) | EPUB | Supplemental
  • 235 Views
  • 11 CrossRef citations
  • 0Altmetric
A rare colonic manifestation of chronic lymphocytic leukemia
Yunseok Namn, Richard R. Furman & Carl Crawford
Pages: 226-229
Published online: 29 Nov 2018
First Page PreviewforA rare colonic manifestation of chronic lymphocytic leukemia | Full Text | References | PDF (1.1 MB) | EPUB | Supplemental
  • 124 Views
  • 0 CrossRef citations
  • 0Altmetric
Rapid complete response to blinatumomab as a successful bridge to allogeneic stem cell transplantation in a case of refractory Richter syndrome
Juan Pablo Alderuccio, Nicholas Mackrides, Jennifer R. Chapman, Francisco Vega & Izidore S. Lossos
Pages: 230-233
Published online: 10 May 2018
First Page PreviewforRapid complete response to blinatumomab as a successful bridge to allogeneic stem cell transplantation in a case of refractory Richter syndrome | Full Text | References | PDF (1 MB) | EPUB | Supplemental
  • 427 Views
  • 14 CrossRef citations
  • 0Altmetric
BIM deletion polymorphism profiling complements prognostic values of risk scores in imatinib-treated Asian chronic myeloid leukemia patients
Hein Than, Weng K. Lye, Colin Sng, John C. Allen Jr, S. Tiong Ong & Charles Chuah
Pages: 234-237
Published online: 19 Jun 2018
First Page PreviewforBIM deletion polymorphism profiling complements prognostic values of risk scores in imatinib-treated Asian chronic myeloid leukemia patients | Full Text | References | PDF (499.1 KB) | EPUB | Supplemental
  • 197 Views
  • 4 CrossRef citations
  • 0Altmetric
Outcome of relapsed or refractory acute myeloid leukemia treated with intensive salvage chemotherapy in real life in comparison to intermediate dose cytarabine in phase 3 studies
Sarah Bertoli, Suzanne Tavitian, Emilie Berard, Noemie Gadaud, Isabelle Luquet, Anne Huynh, Audrey Sarry, Françoise Huguet & Christian Récher
Pages: 238-241
Published online: 12 Jun 2018
First Page PreviewforOutcome of relapsed or refractory acute myeloid leukemia treated with intensive salvage chemotherapy in real life in comparison to intermediate dose cytarabine in phase 3 studies | Full Text | References | PDF (467.3 KB) | EPUB | Supplemental
  • 188 Views
  • 3 CrossRef citations
  • 0Altmetric
Polyreactive antibodies in CLL correlate with the level of immunoglobulins not the number of B lymphocytes
Sreenivasulu Gunti, Sarah E.M. Herman, Raju V.S.R.K. Gottumukkala, Ying Xiong, Clare Sun, Gilberto N. Carmona, Adrian Wiestner & Abner L. Notkins
Pages: 242-245
Published online: 09 May 2018
First Page PreviewforPolyreactive antibodies in CLL correlate with the level of immunoglobulins not the number of B lymphocytes | Full Text | References | PDF (762.7 KB) | EPUB | Supplemental
  • 212 Views
  • 3 CrossRef citations
  • 0Altmetric
Performance of the Medical Research Council (MRC) and the Leukemia Research Foundation (LRF) score in predicting survival benefit with hypomethylating agent use in patients with relapsed or refractory acute myeloid leukemia
Maximilian Stahl, Michelle DeVeaux, Pau Montesinos, Raphaël Itzykson, Ellen K. Ritchie, Mikkael A. Sekeres, John Barnard, Nikolai A. Podoltsev, Andrew Brunner, Rami S. Komrokji, Vijaya R. Bhatt, Aref Al-Kali, Thomas Cluzeau, Valeria Santini, Gail J. Roboz, Pierre Fenaux, Mark Litzow, Amir T. Fathi, Sarah Perreault, Tae Kon Kim, Thomas Prebet, Norbert Vey, Vivek Verma, Ulrich Germing, Juan Bergua, Josefina Serrano, Steven D. Gore & Amer M. Zeidan
Pages: 246-249
Published online: 02 Jul 2018
First Page PreviewforPerformance of the Medical Research Council (MRC) and the Leukemia Research Foundation (LRF) score in predicting survival benefit with hypomethylating agent use in patients with relapsed or refractory acute myeloid leukemia | Full Text | References | PDF (1.2 MB) | EPUB | Supplemental
  • 223 Views
  • 0 CrossRef citations
  • 0Altmetric
Location matters in early stage nodal diffuse large B-cell lymphoma
Konstantinos Lontos, Anastasia Tsagianni, Jian-Min Yuan, Daniel P. Normolle, Michael Boyiadzis, Jing-Zhou Hou, Steven H. Swerdlow & Kathleen A. Dorritie
Pages: 250-253
Published online: 22 Jun 2018
First Page PreviewforLocation matters in early stage nodal diffuse large B-cell lymphoma | Full Text | References | PDF (632.7 KB) | EPUB | Supplemental
  • 194 Views
  • 6 CrossRef citations
  • 0Altmetric
Complete remission of agranulocytosis after splenectomy in a variant form of T-cell large granular lymphocyte leukemia
Claire Lozano, Sophie Brun, Anne Arnaud, Philippe Gaulard, Samia Gonzalez, Julien Crouzet & Jean-Christophe Gris
Pages: 254-257
Published online: 02 Jul 2018
First Page PreviewforComplete remission of agranulocytosis after splenectomy in a variant form of T-cell large granular lymphocyte leukemia | Full Text | References | PDF (1.4 MB) | EPUB | Supplemental
  • 99 Views
  • 0 CrossRef citations
  • 0Altmetric
Prognostic significance of flow cytometry MRD log reduction during induction treatment of childhood ALL
Maria Ampatzidou, Georgios Paterakis, Vassilios Vasdekis, Stephanos I. Papadhimitriou, Vassilios Papadakis, Georgios Vassilopoulos & Sophia Polychronopoulou
Pages: 258-261
Published online: 02 Jul 2018
First Page PreviewforPrognostic significance of flow cytometry MRD log reduction during induction treatment of childhood ALL | Full Text | References | PDF (454.6 KB) | EPUB | Supplemental
  • 126 Views
  • 4 CrossRef citations
  • 0Altmetric
PARP1 inhibitor eliminated imatinib-refractory chronic myeloid leukemia cells in bone marrow microenvironment conditions
Paulina Podszywalow-Bartnicka, Silvia Maifrede, Bac Viet Le, Margaret Nieborowska-Skorska, Katarzyna Piwocka & Tomasz Skorski
Pages: 262-264
Published online: 22 Jun 2018
First Page PreviewforPARP1 inhibitor eliminated imatinib-refractory chronic myeloid leukemia cells in bone marrow microenvironment conditions | Full Text | References | PDF (682.8 KB) | EPUB | Supplemental
  • 264 Views
  • 6 CrossRef citations
  • 0Altmetric
An old misconception: Dutcher bodies are intranuclear inclusions in plasma cells?
Jae Ho Han & Sung Ran Cho
Pages: 265-267
Published online: 30 May 2018
First Page PreviewforAn old misconception: Dutcher bodies are intranuclear inclusions in plasma cells? | Full Text | References | PDF (1 MB) | EPUB | Supplemental
  • 201 Views
  • 0 CrossRef citations
  • 0Altmetric
Towards rational diagnostics in mastocytosis: clinical validation of sensitive KIT D816V mutation analysis of unfractionated whole-blood
Thomas Kristensen, Sigurd Broesby-Olsen, Hanne Vestergaard, Carsten Bindslev-Jensen, Charlotte Gotthard Mortz, Henrik Fomsgaard Kjaer, Michael Boe Møller & on behalf of the Mastocytosis Centre Odense University Hospital (MastOUH)
Pages: 268-270
Published online: 09 May 2018
First Page PreviewforTowards rational diagnostics in mastocytosis: clinical validation of sensitive KIT D816V mutation analysis of unfractionated whole-blood | Full Text | References | PDF (548.7 KB) | EPUB | Supplemental
  • 182 Views
  • 3 CrossRef citations
  • 0Altmetric
Previous exposure to bortezomib is linked to a lower risk of engraftment syndrome after autologous hematopoietic stem cell transplantation
Yasuo Mori, Goichi Yoshimoto, Jun-Ichiro Yuda, Masayasu Hayashi, Jun Odawara, Takuro Kuriyama, Takeshi Sugio, Kohta Miyawaki, Kenjiro Kamezaki, Koji Kato, Katsuto Takenaka, Hiromi Iwasaki, Takahiro Maeda, Toshihiro Miyamoto & Koichi Akashi
Pages: 271-273
Published online: 09 May 2018
First Page PreviewforPrevious exposure to bortezomib is linked to a lower risk of engraftment syndrome after autologous hematopoietic stem cell transplantation | Full Text | References | PDF (308.6 KB) | EPUB | Supplemental
  • 134 Views
  • 2 CrossRef citations
  • 0Altmetric
Autologous stem cell transplant in acute lymphoblastic leukemia: prognostic impact of pre-transplant minimal residual disease
Saveria Capria, Sara Pepe, Silvia Maria Trisolini, Anna Maria Testi, Antonella Vitale, Maria Stefania De Propris, Irene Della Starza, Loredana Elia, Anna Guarini, Sabina Chiaretti & Robin Foà
Pages: 274-276
Published online: 26 Jun 2018
First Page PreviewforAutologous stem cell transplant in acute lymphoblastic leukemia: prognostic impact of pre-transplant minimal residual disease | Full Text | References | PDF (353 KB) | EPUB | Supplemental
  • 207 Views
  • 3 CrossRef citations
  • 0Altmetric
T784C LNK gene polymorphism and the risk of myeloproliferative disorders
Igor A. Olkhovskiy, Aleksey S. Gorbenko, Marina A. Stolyar, Evgeniy V. Vasiliev, Mikhail A. Mikhalev & Kseniya A. Tabakova
Pages: 277-278
Published online: 11 May 2018
CitationforT784C LNK gene polymorphism and the risk of myeloproliferative disorders | Full Text | References | PDF (768.5 KB) | EPUB | Supplemental
  • 83 Views
  • 1 CrossRef citations
  • 0Altmetric

Explore articles